UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 28, 2006
Genelabs Technologies, Inc.
---------------------------
(Exact Name of Registrant as Specified in its Charter)
California 0-19222 94-3010150
- -------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
505 Penobscot Drive, Redwood City, California 94063
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (650) 369-9500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement
On July 28, 2006, the Board of Directors of Genelabs Technologies, Inc.
approved the renewal of the Genelabs Technologies, Inc. Annual and Long-Term
Incentive Based Compensation Program (the "Plan") through February 28, 2007.
A copy of the Plan is filed as Exhibit 10.01 to this Current Report on
Form 8-K, and is incorporated herein by reference.
Item 2.02. Results of Operations and Financial Condition
On August 3, 2006, Genelabs Technologies, Inc. announced its financial
results for the second quarter and first half of 2006. A copy of the related
press release is furnished as Exhibit 99.01 hereto.
The information in this Form 8-K (including Exhibit 99.01) shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the
"Exchange Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
Item 9.01. Financial Statements and Exhibits
(c) Exhibits
Exhibit Number Description
- -------------- -----------
10.01 Registrant's Amended and Renewed 1994 Annual and Long-Term
Incentive Based Compensation Plan.
99.01 Press Release of Registrant, dated August 3, 2006, entitled
"Genelabs Technologies, Inc. Reports Financial Results for
the Second Quarter and First Half of 2006."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Genelabs Technologies, Inc.
Date: August 4, 2006 By: /s/ James Smith
---------------------------
Name: James Smith
Title: Chief Executive Officer
EXHIBIT INDEX
Exhibit Number Description
- -------------- -----------
10.01 Registrant's Amended and Renewed 1994 Annual and Long-Term
Incentive Based Compensation Plan.
99.01 Press Release of Registrant, dated August 3, 2006, entitled
"Genelabs Technologies, Inc. Reports Financial Results for
the Second Quarter and First Half of 2006."